Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial.
about
Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitisCyclosporin A: a new drug in the field of canine dermatologyA treatment study of canine symmetrical onychomadesis (symmetrical lupoid onychodystrophy) comparing fish oil and cyclosporine supplementation in addition to a diet rich in omega-3 fatty acids.Oral cyclosporine treatment in dogs: a review of the literature.Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitisA blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogsA systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.Ciclosporin 10 years on: indications and efficacy.Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes.Reliability and agreement in the use of four- and six-point ordinal scales for the assessment of erythema in digital images of canine skin.Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog.Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs.Evaluation of azithromycin in systemic and toothpaste forms for the treatment of ciclosporin-associated gingival overgrowth in dogs.The effect of ketoconazole on whole blood and skin ciclosporin concentrations in dogs.Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis.Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.Essential fatty acids supplementation in different-stage atopic dogs fed on a controlled diet.Efficacy of cyclosporin in the treatment of atopic dermatitis in dogs--combined results from two veterinary dermatology referral centres.Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study.A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis.Ciclosporin treatment of suspected granulomatous meningoencephalomyelitis in three dogs.Successful immunotherapy of canine flea allergy with injected Actinomycetales preparations.Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.Ciclosporin A therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitis
P2860
Q28196384-9B8FD2A5-F375-4016-BF95-C12CFDF8D7B8Q28251267-CD775E2F-8C36-49CB-BE63-363FCA1B434EQ34306298-E0894352-2B9C-415F-89C4-E05486B02866Q34392104-04119B2A-1707-424E-900E-0D7FECC16F56Q34805412-EB1E09C6-725A-4ED9-822F-6DE7648DE671Q34806216-31FF8119-382D-4124-8D74-4C44F0BCA270Q34866838-FD7EA092-0D7A-4A31-AF9A-884FE7B91E31Q34978147-827C7051-36C9-4938-94F2-C8CA0925F8B7Q35194645-8F8E1873-2669-4105-B16A-B4710E5DDDF3Q35955166-43EF72E9-37A7-4CDC-9F46-13FAD94D1D5EQ36367867-4A80849D-969A-41E5-8CC0-4F843740F4B5Q37634944-CD71C0A3-AB32-44B4-B14F-92C5EE999508Q38200540-5B2A82D7-C5A9-4DE2-B198-94F3C03A346CQ38200541-4A5B5D88-FC1F-4B8A-8CDB-40CF9E419273Q40159932-BC582B5A-1E19-4024-8DDA-3C2D39ED95BBQ40246292-D79D33DD-822A-4E19-8301-E55F296E0669Q42408386-5E827713-7E5D-4A18-98A2-CBC0F0897401Q43198960-6278A9A4-B575-4508-8D43-311FDDACDC08Q43605428-623823A9-2659-4C73-8C70-CFC8EE78686FQ44634059-F3369F8D-7685-4B03-9CD9-187B05BDE2C9Q44869807-6B3CCB20-DA6C-4352-89B2-DD711D2D31BEQ45014641-3A8E0B6E-1EA8-4C24-BE08-9B22C73321C0Q45120688-97A8A0A3-B959-40C3-97C1-78E3ACC0A85AQ46401726-91708A42-C4A6-4677-AEE9-D72B6914AFB3Q46565818-2E63BE82-62A0-46D4-A5AE-8C0A97E52ECBQ47986677-E1E83365-97BA-41B3-A922-E3B524BB6BECQ48347863-F48F9381-76E2-4DD5-9545-D58E2CF1AB1CQ48599627-9EF8BF5A-0349-490F-80DF-5532D0DBCE45Q52726004-813383B7-C78E-4A24-B02E-4CD5BED25BA8Q54582351-0DB4D14D-E729-4FD6-840C-3FD7B9EEA70EQ58772753-5E6E1651-D647-44BF-8264-2BA219C55612
P2860
Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Comparison of cyclosporine A w ...... , randomized controlled trial.
@en
Comparison of cyclosporine A w ...... , randomized controlled trial.
@nl
type
label
Comparison of cyclosporine A w ...... , randomized controlled trial.
@en
Comparison of cyclosporine A w ...... , randomized controlled trial.
@nl
prefLabel
Comparison of cyclosporine A w ...... , randomized controlled trial.
@en
Comparison of cyclosporine A w ...... , randomized controlled trial.
@nl
P2093
P2860
P1476
Comparison of cyclosporine A w ...... , randomized controlled trial.
@en
P2093
Deborah Alexander
Fabienne Brovedani
Jean Steffan
Roland D Fisch
P2860
P356
10.1046/J.1365-3164.2003.00318.X
P577
2003-02-01T00:00:00Z